期刊文献+

妊娠晚期米索前列醇促宫颈成熟给药途径探讨 被引量:6

Study on Administration Routes of Misoprostol for Promoting Cervical Ripening in the Third Trimester of Pregnancy
下载PDF
导出
摘要 目的探讨妊娠晚期米索前列醇促宫颈成熟不同给药途径的优缺点。方法查阅国内外相关文献与行业指南,通过对阴道给药、舌下给药、口服给药3种给药途径的药代动力学、给药剂量与安全性进行比较,阐述米索前列醇用于妊娠晚期促宫颈成熟3种给药途径的优劣。结果阴道给药与舌下给药各具优势;阴道给药生物利用度高,药效延长,但起效稍慢;舌下给药由于达峰迅速,峰浓度更高,可能会引起更多的不良事件发生。结论米索前列醇用于妊娠晚期促宫颈成熟属超说明书用药,在选择米索前列醇用于促宫颈成熟时,应权衡利弊,保证孕妇和胎儿的安全。 Objective To investigate the advantages and disadvantages of different administration routes of misoprostol for promoting cervical ripening in the third trimester of pregnancy. Methods The pharmacokinetics,dose and safety of three routes of administration,such as vaginal administration,sublingual administration and oral administration were compared by referring to the domestic and international literatures and guidelines of clinical research. The advantages and disadvantages of three routes of administration of misoprostol for promoting cervical ripening in the third trimester of pregnancy were described. Results Vaginal and sublingual administration had their own advantages. Vaginal administration had the advantages of high bioavailability,prolonged efficacy,but slower onset of action. Sublingual administration could reach peak concentration rapidly, and peak concentrations were higher than other routes of administration, but it could induce more adverse events. Conclusion Misoprostol used for promoting cervical ripening in the third trimester of pregnancy belongs to off-label drug use. Misoprostol is selected for cervical ripening, the advantages and disadvantages should be evaluated to ensure the safety of pregnant women and fetuses.
作者 柏占锋 奚鑫 杜倩 李文军 黄贵丽 刘松青 Bai Zhanfeng;Xi Xin;Du Qian;Li Wenjun;Huang Guili;Liu Songqing(The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China 401120)
出处 《中国药业》 CAS 2018年第11期81-83,共3页 China Pharmaceuticals
关键词 妊娠晚期 促宫颈成熟 米索前列醇 给药方式 the third trimester of pregnancy cervical ripening misoprostol administration route
  • 相关文献

参考文献8

二级参考文献67

  • 1张小芳.不同剂量米索前列醇与催产素对晚期引产的效果比较[J].延安大学学报(医学科学版),2009,7(4). 被引量:2
  • 2杨艳青,程弘夏,钟大放,文爱东.米索前列醇片人体药动学及生物利用度研究[J].中国医院药学杂志,2006,26(7):817-820. 被引量:6
  • 3Zieman M,Fong SK,Benowitz NL,et al.Absorption kinetics of misoprostol with oral or vaginal administration.Obstet Gynecol,1997,90(1):88-92.
  • 4Khan RU,El-Refaey H,Sharma S,et al.Oral,rectal,and vaginal pharmacokinetics of misoprostol.Obstet Gynecol,2004,103(5 Pt 1):866-870.
  • 5Tang OS,SchweerH,Seyberth HW,et al.Pharmacokinetics of different routes of administration of misoprostol.Human Reproduction,2002,17(2):332-336.
  • 6Zou Y,Chon XY,Song B,et al.Determination of misoprostol acid in human plasma by liquid chromatography coupled to tandem mass spectrometry.Journal of Chromatography B,2007,852(1-2):122-127.
  • 7Fiala C,Aronsson A,Granath F,et al.Pharmacokinetics of a novel oral slow-release form of misoproetol.Hum Reprod,2005,20(12):3414-3418.
  • 8Vermesh M,Fossum GT,Kletzky OA.Vaginal bromocriptive:Pharmacology and effect on serum prolactin in normal women.Obstet Gynecol,1988,72(5):693-697.
  • 9Aronsson A,Fiala C,Stephansson O,et al.Pharmacokinetic profiles up to 12 h after administration of vaginal,sublingual and slow-release oral misoprostol.Hum Reprod,2007,22(7):1912-1918.
  • 10Karim A,Rozek LF,Smith ME,et al.Effects of food and antacid on oral absorption of misoprostol,a synthetic prostaglandin El analog.J clin pharmacol,1989,29(5):439-443.

共引文献944

同被引文献75

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部